Skip to main content
2024 CRT Conference Main banner
Back

CRT 2024

Innovation

FDA Japan

Session Two [Non-CME]

Panel Discussion

Monday, March 11, 2024
11:35 AM – 11:55 AM ET

    Panel Moderator(s)

  • Mitchell Krucoff, MD, FACC

    Professor Medicine/Cardiology
    Duke University Medical Center/Duke Clinical Research Institute
    Durham, North Carolina, United States

    Disclosure information not submitted.

  • Shigeru Saito, MD, FACC, FSCAI

    , Director of Cardiology & Catheterization Laboratories
    Shonan Kamakura General Hospital
    Kamakura, Kanagawa, Japan

    No relationships to disclose

    • Panel Discussant(s)

  • Declan Dineen, BSc, MSc

    Vice President Regulatory Affairs
    Medtronic Inc. , California, United States

    Disclosure(s): Medtronic: Employee (Ongoing)

  • Marika Doi, PhD

    Reviewer, Office of Medical Devices II
    Pharmaceuticals and Medical Devices Agency (PMDA)

    Disclosure(s): No financial relationships to disclose

  • Neal E. Fearnot, PhD

    Vice President
    Cook Group Incorporated
    West Lafayette, Indiana, United States

    No relationships to disclose

  • Nicole Ibrahim, PhD

    Deputy Office Director, OCVD
    U.S. Food and Drug Administration
    Silver Spring, Maryland, United States

    Disclosure(s): No financial relationships to disclose

  • Katherine Kumar, PhD, RAC

    Sr. EVP
    4C Medical Technologies, Inc.
    Minnetonka, Minnesota, United States

    Disclosure information not submitted.

  • Stephen M. Rowland, PhD

    Vice-President, Research and Development
    OrbusNeich Medical Inc.
    Fort Lauderdale, Florida, United States

    Disclosure(s): OrbusNeich Medical: Employee (Ongoing), Salary (Ongoing), Shareholder (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

  • Robert Thatcher, MBA

    CEO at Diaxamed
    Diaxamed, LLC
    Blaine, Minnesota, United States

    No relationships to disclose